Loading...
Images of Piet Wigerinck
(0 from 0 )News
Galapagos initiates second Phase I study with GLPG0974
www.reuters.com
[Reuters] - GLPG0974 targets GPR43, which Galapagos has identified as playing a key role in IBD," said Dr Piet Wigerinck, Chief Scientific Officer of Galapagos. Details of the second Phase I clinical study. The aim of this study is to evaluate the safety
Galapagos gives R&D update - InvestEgate
www.investegate.co.uk
Dr Piet Wigerinck named Chief Scientific Officer. Webcast presentation ... Dr Piet Wigerinck has been named Chief Scientific Officer, responsible for all research and development activities at Galapagos. Dr Wigerinck joined ...
Nieuwe antibiotica ontdekt die ook resistente infecties best
www.nieuwsblad.be
Het biotechbedrijf Galapagos heeft een nieuwe klasse antibiotica ontdekt die ook effectief zijn tegen antibiotica-resistente infecties, zoals de ziekenhuis...
GLPG.NL Company Profile & Executives - Galapagos NV
www.wsj.com
Presently, Piet Wigerinck is Chief Scientific Officer for Galapagos NV. He is also on the board of Ipsen SA, University Hospital Antwerp and miDIAGNOSTICS ... › GLPG › executive-profile
sorted by relevance / date